Dexcel Pharma Technologies Ltd. - Insider Trading & Ownership

Entity
Company
Location
1 Dexcel Street, Or Akiva, Israel
Summary
The estimated value of insider holdings of Dexcel Pharma Technologies Ltd. is at least $1.07B dollars as of November 14, 2022. Dexcel Pharma Technologies Ltd. is the 10%+ Owner of Roivant Sciences Ltd. and owns shares of Roivant Sciences Ltd. (ROIV) stock worth about $1.06B. Dexcel Pharma Technologies Ltd. is the 10%+ Owner of Protalix BioTherapeutics, Inc. and owns shares of Protalix BioTherapeutics, Inc. (PLX) stock worth about $5.13M.
All Insider Reports
All Insider Reports

Ownership of Dexcel Pharma Technologies Ltd.

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
ROIV Roivant Sciences Ltd. 10%+ Owner $1.06B Nov 10, 2022
PLX Protalix BioTherapeutics, Inc. 10%+ Owner $5.13M Jun 2, 2021

Insider Transactions Reported by Dexcel Pharma Technologies Ltd.:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.